Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 29 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (13)
Early P 1 (3)
P 1 (3)
P 2 (6)
P 4 (1)

Trial Status

Recruiting18
Completed5
Active Not Recruiting5
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (29)

Showing 20 of 20 trials
NCT06733350Phase 4RecruitingPrimary

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

NCT05851365Early Phase 1Active Not Recruiting

Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer

NCT02526368Early Phase 1Recruiting

Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer

NCT04530552Phase 2Active Not RecruitingPrimary

Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

NCT07054346Phase 1Recruiting

Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617

NCT07455903Phase 2Not Yet Recruiting

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

NCT05045066Early Phase 1RecruitingPrimary

Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients

NCT05320406Phase 2Active Not Recruiting

RElugolix VErsus LeUprolide Cardiac Trial

NCT06834152RecruitingPrimary

Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer (X-SMILE)

NCT05751434Phase 2Active Not Recruiting

A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

NCT06200974RecruitingPrimary

Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer

NCT04870515Not ApplicableCompletedPrimary

Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study

NCT02600156Not ApplicableCompleted

Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors

NCT06674863Not ApplicableRecruitingPrimary

Addressing Health Literacy With a Tailored Survivorship Care Plan

NCT06500169Not ApplicableRecruitingPrimary

Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors

NCT06940271Not ApplicableRecruitingPrimary

Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy

NCT06389786Not ApplicableRecruitingPrimary

Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer

NCT05786742Not ApplicableRecruiting

Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.

NCT05722288Phase 2RecruitingPrimary

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

NCT05877144Not ApplicableCompleted

LiSWT for Nerve Sparing Radical Prostatectomy ED

Scroll to load more

Research Network

Activity Timeline